KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Stryker (SYK) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Stryker (SYK) over the last 17 years, with Q4 2025 value amounting to $382.2 million.

  • Stryker's Shares Outstanding (Weighted Average) rose 31.5% to $382.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $382.2 million, marking a year-over-year increase of 31.5%. This contributed to the annual value of $382.2 million for FY2025, which is 31.5% up from last year.
  • Stryker's Shares Outstanding (Weighted Average) amounted to $382.2 million in Q4 2025, which was up 31.5% from $382.4 million recorded in Q3 2025.
  • Stryker's Shares Outstanding (Weighted Average)'s 5-year high stood at $382.4 million during Q3 2025, with a 5-year trough of $376.3 million in Q1 2021.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $379.5 million, with a median of $379.6 million in 2023.
  • In the last 5 years, Stryker's Shares Outstanding (Weighted Average) skyrocketed by 40.02% in 2021 and then surged by 31.5% in 2025.
  • Over the past 5 years, Stryker's Shares Outstanding (Weighted Average) (Quarter) stood at $377.0 million in 2021, then grew by 0.32% to $378.2 million in 2022, then grew by 0.37% to $379.6 million in 2023, then grew by 0.37% to $381.0 million in 2024, then rose by 0.31% to $382.2 million in 2025.
  • Its last three reported values are $382.2 million in Q4 2025, $382.4 million for Q3 2025, and $382.2 million during Q2 2025.